Culture

Study reveals significant concerns over growing scale of sex selective abortions in Nepal

image: The findings raises challenges for the Nepali government in relation to sex selective abortion

Image: 
Dr Mahesh Puri

Detailed, new analysis published this week in the British Medical Journal (BMJ) Open highlights significant concerns about a growing issue of sex selective abortion of girls in Nepal.

Drawing on census data from 2011 and follow-on survey data from 2016, the social scientists estimate that roughly one in 50 girl births were 'missing' from records (i.e. had been aborted) between 2006-11 (22,540 girl births in total). In the year before the census (June 2010 - June 2011) this had risen to one in 38.

For certain areas of the country, the practice was more widespread. In Arghakhanchi, the most affected district, one in every six girl births were 'missing' in census data. In the Kathmandu Valley, Nepal's main urban centre, around 115 boys are born for every 100 girls. Without sex selection we would expect only 105 boys born for every 100 girls.

It has been widely acknowledged over many years that sons have been preferred to daughters in Nepal. Whereas boys are seen economic and social assets, in some parts of the country girls are more often regarded as a financial burden, requiring a dowry and leaving their family home upon marriage.

However, it is only since abortion legislation in 2002 and the widespread availability of ultrasounds from 2004 onwards that there has been the potential to selectively abort female foetuses. There has been growing concerns about this practice over recent years, but to date little empirical research about the scale of the issue.

Importantly, abortions due to the results of sex determination tests are both illegal and carry prison sentences in Nepal. But, the researchers writing in the BMJ-Open, suggest that these laws are not effectively enforced. It is estimated that more than half of abortions carried out in 2014 were illegal, so direct legislation only has limited scope to solve this issue.

Deeper analysis by the team found that sex ratios were skewed, with women who were richer and more highly educated more likely to undertake sex selective abortion. They also found that, in districts where more sex-selection occurred, girls were more likely than boys to die by age five, indicating discrimination both before and after birth.

Lead author, Dr Melanie Channon from the University of Bath's Department of Social & Policy Sciences explained: "As fertility falls and urbanisation increases, there is more access to prenatal sex identification technology in Nepal. Our study shows some of the impact this has had over recent years, and we expect there will be a 'trickle-down' of ability to select the sex of a baby from the wealthiest and most educated as the technology becomes more widely available and more affordable. Put simple and starkly, without concerted effort, there will be an increase in sex-selective abortions in Nepal.

"It is important to stress that the solution to this growing issue is not to ban abortion or ultrasound tests during pregnancy. Many lives have been - and continue to be - saved by these policies. The only lasting solution is to dismantle the deeply rooted gender inequity found across the country in order that people no longer wish to selectively abort female foetuses. The government in Nepal needs to take a lead on this, combining media campaigns with legal and political measures which address the issue of gender equity across a range of themes in the country."

Second author of the paper Dr Mahesh Puri from the Center for Research Environment Health and Population Activities (CREHPA) in Nepal, added: "In view of the easy accessibility to prenatal sex-determination technologies, religious and socio-economic values given to sons, coupled with lack of focussed policy and programme to address gender inequality and weak enforcement of law relating to sex determination tests, the practice of sex selective abortion could further increase in the future.

"Targeted interventions to enable gender equality, increase value of girls, as well as social and economic incentives for vulnerable girls, such as conditional cash transfer schemes and effective enforcement of the law would be required."

The team behind the report urge the Nepali government to recognise this issue and adapt a multi-sectoral national strategy to combat it.

Credit: 
University of Bath

Psychologists report an error in the NICE guidelines for autism

Reporting in the Lancet Psychiatry today, psychologists at the University of Bath highlight that a widely used technique for autism screening is being misused, which may have prevented many people from receiving an autism diagnosis over the past decade.

When individuals with suspected autism are assessed by a GP, a decision to refer them to a specialist for diagnosis is informed by using the Autism Spectrum Quotient. This ten-point scale, known as the 'AQ-10', is an internationally used technique, whereby individuals agree or disagree with statements such as 'I find it difficult to work out people's intentions'. The maximum score is ten, and higher scores represent more autistic traits.

A score of six or above on this scale should signal that an individual needs to be referred to a specialist psychologist or psychiatrist. However, through this new research, psychologists have uncovered that for almost ten years the NICE guidelines have incorrectly been recommending a score of 'more than 6 out of 10'. This error may have consequently prevented people who scored '6' from receiving proper support.

The Bath team were surprised to discover this error, and closely analysed the original research about the autism screening tool in comparison with the NICE guidance. They found that the NICE Guideline Development Group had considered, but rejected, a cut-off score for diagnosis of seven or above (?7). In their Lancet article, they conclude that the NICE recommendation of a score "more than 6 out of 10" is an error.

The researchers say that the use of an inappropriately high cut-off score makes this autism screening tool less sensitive, and therefore less accurate. Because it is so widely used among GPs and other healthcare professionals, this issue will be contributing to missed autism referrals, diagnoses, and opportunities for intervention and support. Although clinicians are not solely reliant on AQ-10 scores to make referrals, it factors into their decision-making process. As the NICE AQ-10 guidelines have been in place for almost a decade, the consequences of this mistake will be considerable.

Until the erroneous guidelines are corrected by NICE, the psychologists are calling for an urgent review into this matter, so that pending diagnoses are not missed and that any errors in previous screening can be rectified. In their paper, they recommend that clinicians and researchers use the cut-off score of "6 or above" (?6) instead of NICE's "more than 6 out of 10" (?7) to inform their work.

Dr Punit Shah, Associate Professor of Psychology at the University of Bath and the GW4 Neurodevelopmental Neurodiversity Network, explained: "This is a worrying finding as cut-off scores on screening tools underpin their accuracy. Although a difference of 1-point might not seem huge, a 1-point increased cut-off score on a 10-point scale is substantial and makes the instrument less psychologically sensitive. This means that many people going to their GPs who genuinely have autism - perhaps scoring 6 on the scale - are currently less likely to be referred to specialists for full diagnostic assessment. Diagnosis is of course crucial: without a diagnosis, people have less access to appropriate interventions and support, even certain benefits.

"It is impossible to put a number on exactly how many people will have been affected by this, but it is well known that delayed referrals and late diagnoses of autism have negative consequences for the mental health and wellbeing of autistic people and their families. We urgently need to do all we can to raise awareness of this issue, among GPs and other clinicians, while the NICE guidelines are corrected. NHS waiting times for autism assessments are already far too long and these flaws in screening procedures will be compounding this issue."

Lucy Waldren, lead author of the article also of the Department of Psychology at Bath, suggests the findings have implications for autism and psychiatry research. She says: "Our examination of the literature has discovered that the erroneous NICE guidelines have caused major confusion amongst researchers on which cut-off scores to use. We have found several examples of the incorrect value being applied. Participants in studies have also been inappropriately excluded based on their scores. And, even when the correct value was used, it has been incorrectly attributed to the NICE guidance. If researchers have followed the incorrect NICE guidelines and used the AQ-10 incorrectly in their studies, they may need to reanalyse and republish, or even consider retracting their findings."

Credit: 
University of Bath

Could leak in blood-brain barrier be cause of poor memory?

Have you forgotten where you laid your keys? Ever wondered where you had parked your car? Or having trouble remembering the name of the new neighbor? Unfortunately, these things seem to get worse as one gets older. A big question for researchers is where does benign forgetfulness end and true disease begin?

One of the keys to having a healthy brain at any age is having a healthy blood-brain barrier, a complex interface of blood vessels that run through the brain. Researchers reviewed more than 150 articles to look at what happens to the blood-brain barrier as we age. Their findings were published March 15 in Nature Aging.

Whether the changes to the blood-brain barrier alters brain function, however, is still up for debate.

"It turns out very little is known how the blood-brain barrier ages," said lead author William Banks, a gerontology researcher at the University of Washington School of Medicine, and a researcher with the Geriatrics Research Education and Clinical Center at the Veterans Affairs Puget Sound Health Care System. "It's often hard to tell normal aging from early disease."

The blood-brain barrier, discovered in the late 1800s, prevents the unregulated leakage of substances from blood into the brain. The brain is an especially sensitive organ and cannot tolerate direct exposure to many of the substances in the blood. Increasingly, scientists have realized that the blood-brain barrier also allows many substances into the brain in a regulated way to serve the nutritional needs of the brain. It also transports informational molecules from the blood to the brain and pumps toxins out of the brain. A malfunctioning blood-brain barrier can contribute to diseases such as multiple sclerosis, diabetes, and even Alzheimer's disease.

Before scientists can understand how such malfunctioning can contribute to the diseases of aging, they need to understand how a healthy blood-brain barrier normally ages.

Research shows that healthy aging individuals have a very small leak in their blood-brain barrier. This leakage is associated with some measures of the benign forgetfulness of aging, considered by most scientists to be normal. But could this leak and the difficulties in recall be the early stages of Alzheimer's disease?

When a person carries the ApoE4 allele, the strongest genetic risk of Alzheimer's risk, researchers said there is an acceleration of most of the blood-brain barrier age-related changes.

People with ApoE4 have a hard time getting rid of amyloid beta peptide in their brains, which causes an accumulation of plaque. With healthy aging, the pumps in the blood-brain barrier work less efficiently in getting rid of the amyloid beta peptide. The pumps work even less well in people with Alzheimer's disease.

Another key finding in the review is that as we age, two cells begin to change in the blood-brain barrier: pericytes and astrocytes.

Recent work suggests that the leak in the blood-brain barrier that occurs with Alzheimer's may be due to an age-related loss of pericytes. Astrocytes, by contrast, seem to be overactive. Recent work suggests that preserving pericyte function by giving the factors that they secrete or even transplanting them could lead to a healthier blood-brain barrier.

Some research suggests that pericyte health can be preserved by some of the same interventions that extend lifespan, such as regular exercise, caloric restriction, and rapamycin.

Other findings raise the question of whether the brain's source of nutrition and its grip on control of the immune and endocrine systems could deteriorate with aging. Another finding raises the possibility that the rate at which many drugs are taken up by the brain may explain why older folks sometimes have different sensitivities to drugs than their children or grandchildren.

Credit: 
University of Washington School of Medicine/UW Medicine

Sugar tax in Spain has led to only tiny reduction in calories in shopping basket

The introduction of a sugar tax, increasing the price of fizzy drinks and other products high in sugar content, has had only a limited, moderate effect in shifting people's dietary habits and behaviours, according to a new study.

Fresh research from an international team of economists published in the journal Social Science & Medicine, focused on the impact of a sugar tax on people's shopping baskets comparing customer spending in Catalonia in Spain (where a tax had been introduced), with the rest of the country (where it had not been) from May 2016 - April 2018.

A sugar-sweetened beverages (SSB) tax was in introduced in Catalonia in May 2017, but not for the rest of Spain. The tax has a tiered structure whereby the rate increases dependent on the amount of sugar contained within a product. The Catalonian approach mirrors that of the UK Soft Drinks Industry Levy, which came into force on 6 April 2018.

The SSB tax meant that, on average, a one litre bottle of Fanta, Sprite or Seven Up!, which cost around €1.02 the month before the tax increased to €1.18. However, one of the additional effects of tax has been reformulation - whereby drinks producers have created and marketed new products with much lower overall sugar content (e.g. Coke Zero).

Drawing on customer data derived from loyalty cards at a Spanish supermarket chain and comparing shopping baskets for nearly a million households (844,943) both before and after the tax was introduced, the research team found that households did reduce purchases of high sugar (taxed) beverages and increased purchases of lower sugar (untaxed) options in response.

However, this reduction was modest. Overall, they calculated this led to an average reduction in sugar of 2.2%, which spread out on a per person basis equalled only a tiny, 3.7 calories per month. Their results also showed a distributional effect with regular (i.e. those doing most of their shopping at this supermarket chain) and high-income customers most affected by the tax.

This might be either due to the fact that the tax was more salient for these groups or that these groups represented the largest share of the sample. Consequently, the researchers argue that much more is needed to influence behaviours and reduce obesity in particular among poorer households.

Lead researcher, Dr Eleonora Fichera from the Department of Economics at the University of Bath (UK) explains: "In response to rising levels of obesity and the serious and significant negative effects this is having for individuals, their families and wider healthcare systems, over the past five years there has been growing interest in the potential effectiveness of sugar taxes.

"By analysing the effect of a tiered tax system for sugar-sweetened beverages in Catalonia and by comparing its impact with the rest of Spain (where a tax was not introduced) our results provide important evidence to policymakers keen to explore the potential effectiveness of this approach.

"And whilst our results demonstrate some impact in shifting behaviours towards products lower in sugar, this effect is modest at best. If these taxes are to be more effective, they need to be more visible at the checkout so that consumers become increasingly aware of the added cost of their high-sugar choices. This requires that the tax is more specific too, ensuring producers are forced to pass the tax through to consumers. Although more than 20% of the Catalan tax was passed through to consumers, not all of it was, making the tax less impactful."

A wide range of additional policies have recently been introduced to tackle growing obesity, including high sugar and high calorie labelling as well as different taxes. In August 2020, Dr Fichera published separate research suggesting that nutritional labelling is helping to improve the nation's diet.

She added: "There is no one, single, silver bullet which will resolve the obesity crisis that many countries in the West are facing. Obesity is a complex problem, exacerbated by a proliferation of high-sugar, high-fat products but also our increasingly sedentary lifestyles. Our approach to tackle it needs to be holistic and co-ordinated."

Credit: 
University of Bath

Therapy for most common cause of cystic fibrosis safe and effective in 6-11

An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.

For children in this age group who have only one copy of F508del mutation - or about 40 percent of patients with cystic fibrosis in the United States - this would be the first treatment that addresses the underlying genetic defect in cystic fibrosis.

This three-drug cystic fibrosis treatment was approved by the FDA in October 2019 for people 12 years and older with at least one copy of F508del mutation. Based on the positive results of this study, the FDA has accepted the application to expand treatment indication to younger children, with a decision expected by June 2021.

"The most exciting aspect of our findings is that this population of children had normal lung function at the start of the study and still had a significant improvement," said Dr. McColley, Co-Global Principal Investigator on the study and senior author, who is the Scientific Director for Interdisciplinary Research Partnerships at Stanley Manne Children's Research Institute at Lurie Children's and Professor of Pediatrics at Northwestern University Feinberg School of Medicine. "Coupled with what we saw in studies and in practice with the older population, starting treatment earlier may avert serious long-term complications and really change the trajectory of health for children with cystic fibrosis."

Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. Currently, average life expectancy is 47 years. The disease is caused by mutations in the CFTR gene that lead to insufficient flow of salt and water in and out of cells. In the lungs, this creates buildup of thick, sticky mucus that can result in chronic lung infections and severe lung disease. Damage to the pancreas occurs even before birth, which interferes with nutrition absorption and growth. While there are approximately 2,000 known mutations of the CFTR gene, the most common is the F508del mutation.

In the 24-week study with 66 children, published in the American Journal of Respiratory Care and Critical Care Medicine, Dr. McColley and colleagues confirmed the appropriateness of a dose that is half of the adult daily dose of the three-drug treatment for children 6-11 years of age who weigh less than 30 kg and of the full adult dose for those weighing more. The regimen was well tolerated, and the safety profile was generally consistent with that observed in older patients, with cough, headache and fever as the most common adverse events.

The treatment resulted in significant improvements in lung function, respiratory symptoms and nutritional status. Maintaining or improving nutritional status is associated with better lung function and increased survival in patients with cystic fibrosis. In addition, substantial improvement in sweat chloride concentration, a direct measure of CFTR function, was observed.

"In this study, we saw greater improvements in sweat chloride than those previously seen in adults and adolescents," said Dr. McColley. "This strong response to treatment may lead to better long-term clinical outcomes of cystic fibrosis."

"It's important to note that people with cystic fibrosis who are demographically characterized as having a race other than white or ethnicity characterized as Hispanic are less likely to have an F508del mutation," Dr. McColley said. "This is important because as with other acute and chronic conditions, these populations have more severe disease and lower life expectancy. As drug development continues, we are focused on having a highly effective treatment or cure for everyone with cystic fibrosis."

Credit: 
Ann & Robert H. Lurie Children's Hospital of Chicago

Chemical cocktail creates new avenues for generating muscle stem cells

image: Microscope image showing muscle stem cells produced using the newly discovered chemical cocktail. Muscle cells, in red, are integrating into injured muscle, in green, of an adult mouse.

Image: 
UCLA Broad Stem Cell Research Center

A UCLA-led research team has identified a chemical cocktail that enables the production of large numbers of muscle stem cells, which can self-renew and give rise to all types of skeletal muscle cells.

The advance could lead to the development of stem cell-based therapies for muscle loss or damage due to injury, age or disease. The research was published in Nature Biomedical Engineering.

Muscle stem cells are responsible for muscle growth, repair and regeneration following injury throughout a person's life. In fully grown adults, muscle stem cells are quiescent -- they remain inactive until they are called to respond to injury by self-replicating and creating all of the cell types necessary to repair damaged tissue.

But that regenerative capacity decreases as people age; it also can be compromised by traumatic injuries and by genetic diseases such as Duchenne muscular dystrophy.

"Muscle stem cell-based therapies show a lot of promise for improving muscle regeneration, but current methods for generating patient-specific muscle stem cells can take months," said Song Li, the study's senior author and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

Li and his colleagues identified a chemical cocktail -- a combination of the root extract forskolin and the small molecule RepSox -- that can efficiently create large numbers of muscle stem cells within 10 days. In mouse studies, the researchers demonstrated two potential avenues by which the cocktail could be used as a therapy.

The first method uses cells found in the skin called dermal myogenic cells, which have the capacity to become muscle cells. The team discovered that treating dermal myogenic cells with the chemical cocktail drove them to produce large numbers of muscle stem cells, which could then be transplanted into injured tissue.

Li's team tested that approach in three groups of mice with muscle injuries: adult (8-week-old) mice, elderly (18-month-old) mice and adult mice with a genetic mutation similar to the one that causes Duchenne in humans.

Four weeks after the cells were transplanted, the muscle stem cells had integrated into the damaged muscle and significantly improved muscle function in all three groups of mice.

For the second method, Li's team used nanoparticles to deliver the chemical cocktail into damaged muscle tissue. The nanoparticles, which are about one one-hundredth the size of a grain of sand, are made of the same material as dissolvable surgical stitches, and they are designed to release the chemicals slowly as they break down.

The second approach also produced a robust repair response in all three types of mice. When injected into injured muscle, the nanoparticles migrated throughout the injured area and released the chemicals, which activated the quiescent muscle stem cells to begin dividing.

While both techniques were successful, the key benefit of the second one is that it eliminated the need for growing cells in the lab -- all of the muscle stem cell activation and regeneration takes place inside the body.

The team was particularly surprised to find that the second method was effective even in elderly mice, in spite of the fact that as animals age, the environment that surrounds and supports muscle stem cells becomes less effective.

"Our chemical cocktail enabled muscle stem cells in elderly mice to overcome their adverse environment and launch a robust repair response," said Li, who is also chair of bioengineering at the UCLA Samueli School of Engineering and professor of medicine at the David Geffen School of Medicine at UCLA.

In future studies, the research team will attempt to replicate the results in human cells and monitor the effects of the therapy in animals for a longer period. The experiments should help determine if either approach could be used as a one-time treatment for patients with serious injuries.

Li noted that neither approach would fix the genetic defect that causes Duchenne or other genetic muscular dystrophies. However, the team envisions that muscle stem cells generated from a healthy donor's skin cells could be transplanted into a muscular dystrophy patient's muscle -- such as in the lungs -- which could extend their lifespan and improve their quality of life.

Credit: 
University of California - Los Angeles Health Sciences

Mobile stroke units improve outcomes and reduce disability among stroke patients

DALLAS, March 17, 2021 -- Stroke patients treated via a mobile stroke unit (MSU) received clot-busting medications faster and more often - and recovered significantly better than patients who receive regular emergency care by standard ambulance, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

"Our goal in this study was to treat patients on the mobile stroke unit within an hour of the onset of their stroke symptoms, and we were gratified that one-third of the patients were actually treated within that time frame," said James C. Grotta, M.D., lead study author and director of stroke research at the Clinical Institute for Research and Innovation at Memorial Hermann - Texas Medical Center in Houston. "Our study confirmed that patients who are treated early benefit from a complete reversal of stroke symptoms and avoidance of disability. This suggests that in the first hour after a stroke occurs, the brain is not yet irreversibly damaged and is very amenable to effective treatment."

Mobile stroke units are special ambulances equipped to diagnose and treat stroke quickly. When a stroke is caused by a blood clot blocking an artery in or leading to the brain (an ischemic stroke), the team on board the mobile stroke unit can treat the patient right away with a clot-dissolving medication called tissue plasminogen activator (tPA).

This research, which is part of the ongoing, national BEST-MSU study, examined data from 1,047 patients who suffered an ischemic stroke and were eligible for tPA treated at seven U.S. centers (Houston; Aurora, Colorado; New York City; Indianapolis; Los Angeles; Memphis, Tennessee; and Burlingame, California) between 2014 and 2020. Researchers compared outcomes of stroke patients brought to the emergency department by mobile stroke unit versus those who arrived by standard emergency medical services (617 patients via mobile stroke unit, and 430 patients via standard ambulance).

They found:

Overall, 97% of patients transported by a mobile stroke unit received tPA, compared to 80% of those brought to the emergency department by a regular ambulance.

One-third of the patients treated by a mobile stroke unit were treated within one hour after the onset of stroke symptoms, compared to only 3% of patients transported by a standard ambulance.

53% of the patients treated by a mobile stroke unit made a complete recovery from the stroke after three months while 43% of the patients treated by a standard ambulance achieved a full recovery.

"Our results mean that, on average, for every 100 patients treated on a mobile stroke unit rather than standard ambulance, 27 will have less final disability and 11 of the 27 will be disability-free," Grotta said. "But for this to happen, patients, caregivers and bystanders need to recognize the signs of stroke and call 9-1-1 immediately."

"More widespread deployment of mobile stroke units may have a major public health impact on reducing disability from stroke," said Grotta. "Although mobile stroke units are costly to equip and staff, they reduce the time to treatment. We also expect that more treatment via mobile stroke units can reduce the need for downstream utilization of long-term care."

More research is ongoing by Grotta and his team to assess health care utilization over the entire year following their patients' strokes which will enable a better idea of the cost effectiveness of mobile stroke unit implementation on a wider scale. The American Heart Association's 2019 Recommendations for the Establishment of Stroke Systems of Care suggests reimbursement is an issue that warrants further investigation before widespread use of mobile stroke units is likely.

Credit: 
American Heart Association

Illinois youth opioid use linked with other substance misuse, mental health issues

image: University of Illinois researchers Allen Barton (left) and Doug Smith found opioid use among Illinois high school students tied to other substance use and mental health concerns.

Image: 
Photo: L. Brian Stauffer, University of Illinois.

URBANA, Ill. - Opioid use has dramatically increased in the 21st century, especially among young adults. A new study from the University of Illinois provides insights on usage patterns among Illinois high school students to help inform prevention and treatment strategies.

"The societal and personal costs of opioid misuse are massive. There's been a lot of focus on trying to understand how to combat the current epidemic. But we also need to make sure we have good data in order to know how we should apply our efforts," says Allen Barton, assistant professor in the Department of Human Development and Family Studies at U of I and lead author on the study.

The researchers based their study on information from the 2018 Illinois Youth Survey (IYS), which measures risk behaviors among high school students.

Over 230,000 students across Illinois typically participate in the biannual survey, says Doug Smith, professor of social work and director of the Center for Prevention Research and Development at U of I. Smith is co-author on the opioid study and principal investigator for the IYS.

The study focused on 18-to 19-year-olds, the beginning of a developmental stage when opioid use vulnerability is highest, Barton says.

Among the more than 26,000 respondents in this age group, 5.6% (1,468 youth) indicated they had used prescription pain medication in the past year without a prescription or differently than intended; that is, non-medical use of prescription opioids.

"Another 2.6% (682 youth) reported they had used prescription painkillers to get high. This addresses motive of use, which is an important part of understanding the issue," Barton says.

Finally, 0.4% of the sample (105 youth) reported they had used heroin in the past year. Heroin is another form of opioid that is not in the form of prescription medication, Barton notes.

The researchers found clear differences in characteristics of opioid users versus non-users.

"The individuals engaging in opioid use are also engaging in heightened levels of other forms of substance misuse, primarily alcohol and cannabis. They have more mental health concerns and higher suicide intent. And those who are using opioids report much lower grades and much higher levels of being victims of bullying," Barton says.

As opioid use is closely linked with other forms of substance misuse, counselors and medical practitioners should treat it as part of a pattern, Smith states. "This contradicts the typical image of a non-substance-using youth who one day decides to use opioids and then gets progressively addicted. That doesn't typically happen. These kids are already using other substances, often at levels indicative of problematic use. It seems more like a progression of general substance use than specific opioid usage," he notes.

The researchers also analyzed the data to look for profiles among the subset of youth using opioids.

"Our findings indicated three main profiles of individuals reporting opioid use. You have one group, comprising slightly more than half of this subsample, that's using opioids, but not specifically to get high. You have another group of individuals reporting a clear motive of use to get high. And a third, small group that's just using heroin," Barton notes.

While there were many similarities among the three groups, individuals who reported using opioids to get high also reported much more problematic substance abuse overall, as well as higher suicide risk compared to people who are engaged in non-medical use of prescription opioids without such motive, Smith adds.

The researchers say their study shows opioid use is a complex issue which needs tailored approaches to treatment and prevention.

"In order to address opioid use at this developmental stage, which is a transition to adulthood, we need to realize it is indicative of a broader pattern of factors related to other substance use and mental health issues that require attention. A one-step approach to just address the opioid use may not be sufficient," Barton states.

"The good news in this data is that opioid use rates are very low for this demographic across the state. However, for a subset of youth who do use, it appears to be making a difficult situation all the more challenging."

Barton and Smith say the correlation with other forms of substance misuse can help identify opioid use at an early stage.

"For any youth who is getting treatment for another substance, we need to be screening for whether they're using opioids, and we need to have a prevention program within a treatment program," Smith says.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences

Novel coronavirus circulated undetected months before first COVID-19 cases in Wuhan, China

image: The SARS-CoV-2 virus under a microscope.

Image: 
National Institute of Allergy and Infectious Diseases

Using molecular dating tools and epidemiological simulations, researchers at University of California San Diego School of Medicine, with colleagues at the University of Arizona and Illumina, Inc., estimate that the SARS-CoV-2 virus was likely circulating undetected for at most two months before the first human cases of COVID-19 were described in Wuhan, China in late-December 2019.

Writing in the March 18, 2021 online issue of Science, they also note that their simulations suggest that the mutating virus dies out naturally more than three-quarters of the time without causing an epidemic.

"Our study was designed to answer the question of how long could SARS-CoV-2 have circulated in China before it was discovered," said senior author Joel O. Wertheim, PhD, associate professor in the Division of Infectious Diseases and Global Public Health at UC San Diego School of Medicine.

"To answer this question, we combined three important pieces of information: a detailed understanding of how SARS-CoV-2 spread in Wuhan before the lockdown, the genetic diversity of the virus in China and reports of the earliest cases of COVID-19 in China. By combining these disparate lines of evidence, we were able to put an upper limit of mid-October 2019 for when SARS-CoV-2 started circulating in Hubei province."

Cases of COVID-19 were first reported in late-December 2019 in Wuhan, located in the Hubei province of central China. The virus quickly spread beyond Hubei. Chinese authorities cordoned off the region and implemented mitigation measures nationwide. By April 2020, local transmission of the virus was under control but, by then, COVID-19 was pandemic with more than 100 countries reporting cases.

SARS-CoV-2 is a zoonotic coronavirus, believed to have jumped from an unknown animal host to humans. Numerous efforts have been made to identify when the virus first began spreading among humans, based on investigations of early-diagnosed cases of COVID-19. The first cluster of cases -- and the earliest sequenced SARS-CoV-2 genomes -- were associated with the Huanan Seafood Wholesale Market, but study authors say the market cluster is unlikely to have marked the beginning of the pandemic because the earliest documented COVID-19 cases had no connection to the market.

Regional newspaper reports suggest COVID-19 diagnoses in Hubei date back to at least November 17, 2019, suggesting the virus was already actively circulating when Chinese authorities enacted public health measures.

In the new study, researchers used molecular clock evolutionary analyses to try to home in on when the first, or index, case of SARS-CoV-2 occurred. "Molecular clock" is a term for a technique that uses the mutation rate of genes to deduce when two or more life forms diverged -- in this case, when the common ancestor of all variants of SARS-CoV-2 existed, estimated in this study to as early as mid-November 2019.

Molecular dating of the most recent common ancestor is often taken to be synonymous with the index case of an emerging disease. However, said co-author Michael Worobey, PhD, professor of ecology and evolutionary biology at University of Arizona: "The index case can conceivably predate the common ancestor -- the actual first case of this outbreak may have occurred days, weeks or even many months before the estimated common ancestor. Determining the length of that 'phylogenetic fuse' was at the heart of our investigation."

Based on this work, the researchers estimate that the median number of persons infected with SARS-CoV-2 in China was less than one until November 4, 2019. Thirteen days later, it was four individuals, and just nine on December 1, 2019. The first hospitalizations in Wuhan with a condition later identified as COVID-19 occurred in mid-December.

Study authors used a variety of analytical tools to model how the SARS-CoV-2 virus may have behaved during the initial outbreak and early days of the pandemic when it was largely an unknown entity and the scope of the public health threat not yet fully realized.

“These tools included epidemic simulations based on the virus’s known biology, such as its transmissibility and other factors, developed by study co-author Niema Moshiri, PhD, assistant teaching professor in the Department of Computer Science and Engineering at UC San Diego. In just 29.7 percent of these simulations was the virus able to create self-sustaining epidemics. In the other 70.3 percent, the virus infected relatively few persons before dying out. The average failed epidemic ended just eight days after the index case.”

"Our approach yielded some surprising results. We saw that over two-thirds of the epidemics we attempted to simulate went extinct. That means that if we could go back in time and repeat 2019 one hundred times, two out of three times, COVID-19 would have fizzled out on its own without igniting a pandemic. This finding supports the notion that humans are constantly being bombarded with zoonotic pathogens."

Wertheim noted that even as SARS-CoV-2 was circulating in China in the fall of 2019, the researchers' model suggests it was doing so at low levels until at least December of that year.

"Given that, it's hard to reconcile these low levels of virus in China with claims of infections in Europe and the U.S. at the same time," Wertheim said. "I am quite skeptical of claims of COVID-19 outside China at that time."

The original strain of SARS-CoV-2 became epidemic, the authors write, because it was widely dispersed, which favors persistence, and because it thrived in urban areas where transmission was easier. In simulated epidemics involving less dense rural communities, epidemics went extinct 94.5 to 99.6 percent of the time.

The virus has since mutated multiple times, with a number of variants becoming more transmissible.

"Pandemic surveillance wasn't prepared for a virus like SARS-CoV-2," Wertheim said. "We were looking for the next SARS or MERS, something that killed people at a high rate, but in hindsight, we see how a highly transmissible virus with a modest mortality rate can also lay the world low."

Credit: 
University of California - San Diego

Researchers identify DNA elements that affect MECP2 expression

Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital (NRI) have identified and characterized two regions of DNA required for the proper expression of Mecp2/MECP2 in mice and humans.

These findings, published in Genes & Development, are helping to shed light on the function of these DNA regions and how they could be potential targets for diagnostic and therapeutic interventions for intellectual disabilities such as Rett Syndrome and MECP2 Duplication Syndrome.

Both of these intellectual disabilities are examples of the importance of precise MeCP2 protein levels for proper brain function. A decrease in this protein leads to Rett Syndrome, while an increase in this protein causes MECP2 Duplication Syndrome. Both are severe neurological disorders characterized by learning disabilities, features of autism and motor difficulties.

Dr. Huda Zoghbi, professor at Baylor, director of the NRI, and a Howard Hughes Medical Institute investigator, underscored the importance of understanding how the levels of RNA encoding this protein are regulated. Researchers in her lab identified two DNA regions that, when mutated, lead to either a decrease or an increase in MECP2 RNA and protein levels, resulting in partial behavioral deficits seen in Rett Syndrome and MECP2 Duplication Syndrome, respectively.

Yingyao Shao, first author on the study and graduate student in the Zoghbi lab, explains that when one of the two DNA regions were altered, results showed a moderate reduction in MeCP2 levels mimicking behavioral and molecular changes observed in Rett mice models. Alteration of the other DNA region caused a slight increase in MeCP2 protein levels similar to mice models with double expression of MeCP2.

"These findings provide hope that future treatments targeting these DNA regions could have clinically relevant benefits, even when only slightly correcting MeCP2 protein levels," said Shao. "Moreover, mutations in either of these two DNA regions are likely to cause intellectual disability or autism in humans, thus it is important to sequence these regions when screening for genetic causes of neurodevelopmental disorders," added Zoghbi.

Credit: 
Baylor College of Medicine

Powerful stratospheric winds measured on Jupiter for the first time

image: This image shows an artist's impression of winds in Jupiter's stratosphere near the planet's south pole, with the blue lines representing wind speeds. These lines are superimposed on a real image of Jupiter, taken by the JunoCam imager aboard NASA's Juno spacecraft.

Jupiter's famous bands of clouds are located in the lower atmosphere, where winds have previously been measured. But tracking winds right above this atmospheric layer, in the stratosphere, is much harder since no clouds exist there. By analysing the aftermath of a comet collision from the 1990s and using the ALMA telescope, in which ESO is a partner, researchers have been able to reveal incredibly powerful stratospheric winds, with speeds of up to 1450 kilometres an hour, near Jupiter's poles.

Image: 
ESO/L. Calçada & NASA/JPL-Caltech/SwRI/MSSS

Using the Atacama Large Millimeter/submillimeter Array (ALMA), in which the European Southern Observatory (ESO) is a partner, a team of astronomers have directly measured winds in Jupiter's middle atmosphere for the first time. By analysing the aftermath of a comet collision from the 1990s, the researchers have revealed incredibly powerful winds, with speeds of up to 1450 kilometres an hour, near Jupiter's poles. They could represent what the team have described as a "unique meteorological beast in our Solar System".

Jupiter is famous for its distinctive red and white bands: swirling clouds of moving gas that astronomers traditionally use to track winds in Jupiter's lower atmosphere. Astronomers have also seen, near Jupiter's poles, the vivid glows known as aurorae, which appear to be associated with strong winds in the planet's upper atmosphere. But until now, researchers had never been able to directly measure wind patterns in between these two atmospheric layers, in the stratosphere.

Measuring wind speeds in Jupiter's stratosphere using cloud-tracking techniques is impossible because of the absence of clouds in this part of the atmosphere. However, astronomers were provided with an alternative measuring aid in the form of comet Shoemaker-Levy 9 , which collided with the gas giant in spectacular fashion in 1994. This impact produced new molecules in Jupiter's stratosphere, where they have been moving with the winds ever since.

A team of astronomers, led by Thibault Cavalié of the Laboratoire d'Astrophysique de Bordeaux in France, have now tracked one of these molecules -- hydrogen cyanide -- to directly measure stratospheric "jets" on Jupiter. Scientists use the word "jets" to refer to narrow bands of wind in the atmosphere, like Earth's jet streams.

"The most spectacular result is the presence of strong jets, with speeds of up to 400 metres per second, which are located under the aurorae near the poles," says Cavalié. These wind speeds, equivalent to about 1450 kilometres an hour, are more than twice the maximum storm speeds reached in Jupiter's Great Red Spot and over three times the wind speed measured on Earth's strongest tornadoes.

"Our detection indicates that these jets could behave like a giant vortex with a diameter of up to four times that of Earth, and some 900 kilometres in height," explains co-author Bilal Benmahi, also of the Laboratoire d'Astrophysique de Bordeaux. "A vortex of this size would be a unique meteorological beast in our Solar System," Cavalié adds.

Astronomers were aware of strong winds near Jupiter's poles, but much higher up in the atmosphere, hundreds of kilometres above the focus area of the new study, which is published today in Astronomy & Astrophysics. Previous studies predicted that these upper-atmosphere winds would decrease in velocity and disappear well before reaching as deep as the stratosphere. "The new ALMA data tell us the contrary," says Cavalié, adding that finding these strong stratospheric winds near Jupiter's poles was a "real surprise".

The team used 42 of ALMA's 66 high-precision antennas, located in the Atacama Desert in northern Chile, to analyse the hydrogen cyanide molecules that have been moving around in Jupiter's stratosphere since the impact of Shoemaker-Levy 9. The ALMA data allowed them to measure the Doppler shift -- tiny changes in the frequency of the radiation emitted by the molecules -- caused by the winds in this region of the planet. "By measuring this shift, we were able to deduce the speed of the winds much like one could deduce the speed of a passing train by the change in the frequency of the train whistle," explains study co-author Vincent Hue, a planetary scientist at the Southwest Research Institute in the US.

In addition to the surprising polar winds, the team also used ALMA to confirm the existence of strong stratospheric winds around the planet's equator, by directly measuring their speed, also for the first time. The jets spotted in this part of the planet have average speeds of about 600 kilometres an hour.

The ALMA observations required to track stratospheric winds in both the poles and equator of Jupiter took less than 30 minutes of telescope time. "The high levels of detail we achieved in this short time really demonstrate the power of the ALMA observations," says Thomas Greathouse, a scientist at the Southwest Research Institute in the US and co-author of the study. "It is astounding to me to see the first direct measurement of these winds."

"These ALMA results open a new window for the study of Jupiter's auroral regions, which was really unexpected just a few months back," says Cavalié. "They also set the stage for similar yet more extensive measurements to be made by the JUICE mission and its Submillimetre Wave Instrument," Greathouse adds, referring to the European Space Agency's JUpiter ICy moons Explorer, which is expected to launch into space next year.

Credit: 
ESO

Animal model opens way to test Alzheimer's disease therapies

image: Inflammatory cells (red and green) flood into part of the brain where neurons are affected by misfolded tau protein (orange). This model in rhesus macaque monkeys shows similarities to development of Alzheimer's disease in humans and could open up ways to test new treatments.

Image: 
Danielle Beckman, UC Davis/CNPRC

Our knowledge of Alzheimer's disease has grown rapidly in the past few decades but it has proven difficult to translate fundamental discoveries about the disease into new treatments. Now researchers at the California National Primate Research Center at the University of California, Davis, have developed a model of the early stages of Alzheimer's disease in rhesus macaques. The macaque model, published March 18 in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association could allow better testing of new treatments.

The model was developed by Professor John Morrison's laboratory at the CNPRC, in collaboration with Professor Jeffrey Kordower of Rush University Medical Center and Paramita Chakrabarty, assistant professor at the University of Florida.

Alzheimer's disease is thought to be caused by misfolding of the tau and amyloid proteins. Misfolded proteins spread through the brain, leading to inflammation and cell death. Tau protein is commonly found in neurons of the brain and central nervous system, but not elsewhere.

Researchers think that decades may elapse between the silent beginnings of the disease and the first signs of cognitive decline. Understanding what happens over these years could be key to preventing or reversing symptoms of Alzheimer's disease. But it is difficult to study therapeutic strategies without a powerful animal model that resembles the human condition as closely as possible, Morrison said. Much research has focused on transgenic mice that express a human version of amyloid or tau proteins, but these studies have proven difficult to translate into new treatments.

New translational models needed

Humans and monkeys have two forms of the tau protein in their brains, but rodents only have one, said Danielle Beckman, postdoctoral researcher at the CNPRC and first author on the paper.

"We think the macaque is a better model, because it expresses the same versions of tau in the brain as humans do," she said.

Mice also lack certain areas of neocortex such as prefrontal cortex, a region of the human brain that is highly vulnerable to Alzheimer's disease. Prefrontal cortex is present in rhesus macaques and critically important for cognitive functions in both humans and monkeys. There is a critical need for new and better animal models for Alzheimer's disease that can stand between mouse models and human clinical trials, Beckman said.

Chakrabarty and colleagues created versions of the human tau gene with mutations that would cause misfolding, wrapped in a virus particle. These vectors were injected into rhesus macaques, in a brain region called the entorhinal cortex, which is highly vulnerable in Alzheimer's disease.

Within three months, they could see that misfolded tau proteins had spread to other parts of the animal's brains. They found misfolding both of the introduced human mutant tau protein and of the monkey's own tau proteins.

"The pattern of spreading demonstrated unequivocally that tau-based pathology followed the precise connections of the entorhinal cortex and that the seeding of pathological tau could pass from one region to the next through synaptic connections," Morrison said. "This capacity to spread through brain circuits results in the damage to cortical areas responsible for higher level cognition quite distant from the entorhinal cortex," he said.

The same team has previously established spreading of misfolded amyloid proteins in macaques, representing the very early stages of Alzheimer's disease, by injecting short pieces of faulty amyloid. The new tau protein model likely represents a middle stage of the disease, Beckman said.

"We think that this represents a more degenerative phase, but before widespread cell death occurs," she said.

The researchers next plan to test if behavioral changes comparable to human Alzheimer's disease develop in the rhesus macaque model. If so, it could be used to test therapies that prevent misfolding or inflammation.

"We have been working to develop these models for the last four years," Morrison said. "I don't think you could do this without a large collaborative team and the extensive resources of a National Primate Research Center."

Credit: 
University of California - Davis

Four lichen species new to science discovered in Kenyan cloud forests

Researchers from the University of Helsinki's Finnish Museum of Natural History Luomus and the National Museums of Kenya have discovered four lichen species new to science in the rainforests of the Taita Hills in southeast Kenya.

Micarea pumila, M. stellaris, M. taitensis and M. versicolor are small lichens that grow on bark of trees and on decaying wood. The species were described based on morphological features and DNA-characters.

"Species that belong to the Micarea genus are known all over the world, including Finland. However, the Micarea species recently described from the Taita Hills have not been seen anywhere else. They are not known even in the relatively close islands of Madagascar or Réunion, where species of the genus have been previously studied," Postdoctoral Researcher Annina Kantelinen from the Finnish Museum of Natural History says.

"The Taita Hills cloud forests are quite an isolated ecosystem, and at least some of the species now discovered may be native to the area or to eastern Africa. Our preliminary findings also suggest that there are more unknown Micarea lichen species there."

The Taita Hills are part of the Eastern Arc Mountains that range from south-eastern Kenya to eastern Tanzania. The mountains rise abruptly from the surrounding plain, with the tallest peak reaching over two kilometers. Lush indigenous rainforests are mainly found on the mountaintops, capturing precipitation from clouds and mist developed by the relatively cool air rising from the Indian Ocean.

Thanks to ecological isolation and a favourable climate, the area is one of the global hotspots of biodiversity. However, the native cloud forests in the region are shrinking year by year as they are replaced by forest plantations of exotic tree species that are not native to Africa. Compared to 1955, the area of indigenous forests has been diminished to less than half.

"Planted forests have been found to bind less moisture and be more susceptible to forest fires. Therefore, they can make the local ecosystem drier and result in species becoming endangered. Some lichen species are capable of utilising cultivated forests at least temporarily, but indigenous forests have the greatest biodiversity and biomass," Kantelinen says.

The University of Helsinki maintains in the area the Taita Research Station, which is celebrating its tenth anniversary this year.

Credit: 
University of Helsinki

How to get customers to talk about you

Researchers from Arizona State University, New York University, and Northwestern University published a new paper in the Journal of Marketing that examines how marketers can fuel positive WOM without using explicit incentives.

The study, forthcoming in the Journal of Marketing, is titled "How Marketing Perks Influence Word of Mouth" and is authored by Monika Lisjak, Andrea Bonezzi, and Derek Rucker.

Word-of-mouth (WOM) is arguably the most influential means of persuasion and can be a critical driver of a company's growth. For this reason, many companies offer consumers incentives to encourage them to generate WOM. Classic examples of this practice are referral and seeding programs, whereby a company literally "pays" current customers to generate positive WOM and attract new customers. Despite its intuitive appeal, however, this practice can backfire. Ironically, incentivizing WOM sometimes can hamper, rather than increase, consumers' willingness to engage in WOM.

This research shows that commonly used marketing perks--e.g., gifts, benefits, and rewards--can effectively foster WOM without being used as explicit incentives. Their effectiveness at boosting WOM, however, depends on how they are framed and therefore perceived by consumers: Marketing perks are more effective at fostering WOM the less they are perceived to be given out of contractual obligation. The term "contractuality" refers to the degree to which a perk is perceived to be given to consumers in exchange for engaging in specific behaviors dictated by a company, such as filling out a survey or making a certain number of purchases.

Lisjak explains that "We demonstrate that marketers can influence the perceived contractuality of a perk with easily implementable pivots. Consumers can perceive the exact same perk, say a free coffee, as more or less contractual simply based on how it is framed." As one example, the perceived contractuality of a perk can be lowered by giving consumers a free item after a set number of purchases, but not making the number of purchases salient to the consumer. As another example, the same perk could be accompanied by a thank you note, as opposed to a note that highlights all the effort a customer had to put in to earn the perk. In both instances, companies do not have to change the offering, only how consumers perceive it.

Interestingly, however, perks lower in contractuality can sometimes backfire against companies. This is more likely to occur when a perk characterized by low contractuality comes from a disliked or distrusted company. Under such circumstances, consumers become wary of the company's intentions and then interpret the perk as a manipulative act of persuasion driven by ulterior motives. When this happens, perks lower in contractuality in fact hinder rather than fuel WOM. To illustrate, many consumers do not like utility providers or financial institutions. To the extent that such dislike prompts consumers to make hostile attributions of benevolent gestures, such companies might be better off using perks that are higher in contractuality.

Finally, contractuality can entail a trade-off. Despite being more effective at fostering WOM, low contractuality perks might be less effective than high contractuality perks at inducing compliance with a direct request. For example, if a company wants consumers to complete a customer satisfaction survey, offering a high contractuality perk can be more effective and efficient than offering a low contractuality perk. Simply put, when brands have a specific action other than WOM that they would like consumers to take, perks higher in contractuality might serve as better incentives because they make behavior-reward contingencies clear and salient.

Bonezzi summarizes the study by saying "Our findings suggest that marketers could nudge consumers to generate positive WOM by providing them with perks that have fewer strings attached. Of note, this could be achieved at a similar cost to perks that come across as highly contractual."

Credit: 
American Marketing Association

UTSA researcher studies key predictors for college retention

(MARCH 17, 2021) - The current outbreak of COVID-19 has raised many questions about the value of consideration of standardized testing through the admissions process. One of the many Coronavirus cancellations included a growing number of universities to waive SAT and ACT scores as an admissions requirement for 2022 applicants.

With schools shifting their policy to making standardized "test-optional" and possibly permanently phasing out testing scores in the future as some college experts argue that standardized tests create barriers to students which could reduce their likelihood of acceptance.

A new study led by senior research scientist Paul Westrick from the College Board (ACT, Inc.), along with UTSA professor of management, Huy Le, Steve Robbins from the Educational Testing Service, Justin Radunzel ACT, Inc, and Frank Schmidt, professor emeritus of management and entrepreneurship at the University of Iowa shows that the most effective way to predict students' academic success and retention in a student first year of college relies heavily on test scores and grades combined together.

Based on a national representative sample of 189,612 students at 50 institutions, both ACT scores and high school grade point average are correlated to a first-year students' academic performance, the researchers made important contributions on academic persistence.

The study aims to examine the strength of correlation between ACT Composite scores, school grades, and socioeconomic status within the second- and third-year academic performance.

"We believe this research provides important evidence supporting the usefulness of high school GPA and standardized tests as predictors of student successes in colleges and refuting the misconception that the tests are just a proxy for students' socio-economic status," said Le.

The researchers provided valuable insight to determine the factors that best predict the effectiveness and reliability of continuing to use the practice of standardized tests as a measure of student success and whether or not they will persist in college.

"We are hopeful the findings of the study will help colleges in determining factors to be included for making admission decisions," Le added.

The researchers concluded that grades do not only measure academic characteristics but nonacademic characteristics as well. The findings demonstrate that test scores measure cognitive characteristics, while grades measure a combination of characteristics. Including attendance, participation and more.

The research has yielded many studies that have demonstrated the usefulness and validity of the standardized testing for the admission process.

Credit: 
University of Texas at San Antonio